The validation of new CHD1L inhibitors as a therapeutic strategy for cancer
新型 CHD1L 抑制剂作为癌症治疗策略的验证
期刊:Biomedicine & Pharmacotherapy
影响因子:6.9
doi:10.1016/j.biopha.2023.116037
Sophia Clune, Paul Awolade, Qiong Zhou, Hector Esquer, Brock Matter, Jeffrey T Kearns, Timothy Kellett, Damilola Caleb Akintayo, Uday B Kompella, Daniel V LaBarbera